Could Cancer Cells’ Iron Addiction Be Their Achilles Heel?
29th March 2022
A new study from researchers at the University of California, San Francisco (UCSF) has found that cells carrying oncogenic KRAS mutations harbor elevated levels of a specific kind of iron. This iron could be used to activate drugs that target cancer cells, avoiding harm to normal, healthy cells.